Penumbra Inc.

PEN ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $4.7M $14.8M $2.4M $2.2M $4.1M
Depreciation & Amortization $3.8M $2.3M $1.8M $751.0K $677.0K
Depreciation
Amortization $418.0K $0 $0
Stock-Based Compensation $17.8M $14.6M $7.3M $1.4M $886.0K
Net Cash from Operating Activities $12.7M $-12.8M $-20.7M $-6.4M $-3.4M
Investing Activities
Capital Expenditures $12.5M $13.6M $5.5M $3.9M $798.0K
Business Acquisitions $9.3M $0 $0
Net Cash from Investing Activities $-77.7M $687.0K $-85.8M $-37.0M $-1.3M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $104.4M $7.1M $122.8M $42.9M $2.2M
Net Change in Cash $37.4M $-6.3M $16.3M $-841.0K $-3.3M
Free Cash Flow $159.0K $-26.4M $-26.2M $-10.3M $-4.2M
← Newer Page 2 of 2 Older →